Irony? Paper by author whose attorneys sent cease-and-desist letter to Science Fraud retracted

A Brazilian author whose attorneys were the first to send the now-shuttered Science Fraud site a cease-and-desist letter has now had a paper retracted. As Retraction Watch readers may know, Science Fraud shut down earlier this week in response to legal threats. Those threats were preceded by a cease-and-desist letter last month from attorneys for … Continue reading Irony? Paper by author whose attorneys sent cease-and-desist letter to Science Fraud retracted

Journal of Neuroscience retraction, typically opaque, from author with history of errors

The Journal of Neuroscience has retracted a 2011 paper by an international group of scientists, including the prominent Maryland researcher Ronald Dubner, but readers won’t know why. As the notice “explains“:

Serial plagiarists earn lifetime publishing ban from Saudi journal

In April, we wrote about a group of cancer researchers from Tunisia: The M.O. of the group…appears to be quite simple: Find a study that looks easy to “replicate,” change a few of the particulars and submit as if it were a piece of local, original work. One of the papers we cited in that … Continue reading Serial plagiarists earn lifetime publishing ban from Saudi journal

Double bind: Duplication of bandaging paper leads to retraction

The Journal of Vascular Surgery is retracting — with vigor — a paper it published online in March after discovering that the authors had published essentially the same article for the Journal of the European Academy of Dermatology and Venereology some months earlier. Both papers are titled “Randomized controlled trial comparing treatment outcome of two compression … Continue reading Double bind: Duplication of bandaging paper leads to retraction

Retraction for prostate cancer paper duplication leaves authors penitent, “happy”

Perhaps fittingly in today’s age of sensitive feelings, the typical reaction to a retraction (per the notices, at least) is apology. But bliss? Expert Opinion on Investigational Drugs has a new one in the annals of penitence. At issue is a 2010 paper titled “Horizon scanning for novel therapeutics for the treatment of prostate cancer,” … Continue reading Retraction for prostate cancer paper duplication leaves authors penitent, “happy”

Ovarian transplant update: Authors of 2004 live-birth follow-up letter ask Lancet to retract it

Yesterday, we brought you news of a story in Belgium involving questions about whether a woman who gave birth following an ovarian transplant could have become pregnant without the transplant. The case, which led to a university investigation but no retraction, included allegations of theft and arson. This morning, we were made aware of a … Continue reading Ovarian transplant update: Authors of 2004 live-birth follow-up letter ask Lancet to retract it

Serial plagiarizers banned from dermatology journal forever

Last August, we brought you the news that the Indian Journal of Dermatology had banned a group of Tunisian researchers from publishing in the journal for five years, because they had plagiarized in a 2009 study. Well, the journal’s editors found another case in which the authors have plagiarized, and now they’re banned from the … Continue reading Serial plagiarizers banned from dermatology journal forever

Catching up: Charges against CFS-XMRV researcher Mikovits dropped, ‘gyres’ author Andrulis publishes another paper

A follow-up on two stories we’ve covered here at Retraction Watch: 1. Criminal charges against chronic fatigue syndrome researcher dropped The state of Nevada has dropped criminal charges against Judy Mikovits, the embattled chronic fatigue syndrome (CFS) researcher whose paper linking the condition to a virus, XMRV, was retracted last year by Science. As we … Continue reading Catching up: Charges against CFS-XMRV researcher Mikovits dropped, ‘gyres’ author Andrulis publishes another paper

Authors’ public dispute over retraction notice in Cytokine ends in a draw, bruises journal

Cytokine had an interesting retraction notice this year that points up the pitfalls — perhaps necessary, perhaps not — that journals can step in when they give authors the benefit of the doubt. Here’s the story: A doctoral student named Varun Kesherwani was working in the lab of Ajit Sodhi, a U.S.-trained and well-published cell biologist … Continue reading Authors’ public dispute over retraction notice in Cytokine ends in a draw, bruises journal

Neurochemistry journal retracts paper after earlier mega-correction for an author who’s no stranger to errata

The Journal of Neurochemistry has retracted a 2008 paper, “Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury,” it had initially corrected — and how. The correction, which appeared online in August 2010, was extensive: